|
|
A New Era of COVID-19
With the emergence and spread of the BA.2.75, BA.4 and BA.5 omicron subvariants, IMF Chairman of the Board and Chief Scientific Officer Dr. Brian G.M. Durie discusses how COVID-19 fatigue is taking its toll and emphasizes how important it is to remain constantly vigilant about our safety and protection against a COVID-19 infection. In his blog, Dr. Durie provides a wealth of helpful information to raise further awareness about these new subvariants as well as a must-do list for myeloma patients in this new era of COVID-19. He also highlights the importance of keeping a positive attitude and of getting the support of family and friends in getting through a rough day. In conclusion, Dr. Durie points out how constant new knowledge can reveal new and better answers. He remains hopeful that new advances both in COVID-19 and myeloma will yield the best prevention strategies and that possibly, a cure for myeloma will no longer be elusive in the near future.
|
|
|
|
|
|
|
2021 Susie Novis Durie Educational Grants Awarded at 2022 GMAN Summit
2021 Susie Novis Durie (SND) Educational Grants were recently awarded during the 2022 Annual GMAN Summit. The SND Educational Grants are awarded annually and were created to help member organizations of the IMF’s Global Myeloma Action Network (GMAN) increase education, awareness, and access to treatment. Get to know more about the 2021 SND Educational Grant awardees and the exemplary work they have accomplished for 2021.
|
|
|
|
|
|
|
Karyopharm and Menarini Group Receive Full Marketing Authorization from EC for Nexpovio for the Treatment of Multiple Myeloma Patients After at Least One Prior Therapy
Karyopharm Therapeutics Inc. and the Menarini Group today announced that the European Commission (EC) has granted Marketing Authorization for NEXPOVIO® (selinexor), a first-in-class, oral exportin 1 (XPO1) inhibitor, in combination with once-weekly bortezomib (VELCADE®) and low-dose dexamethasone (SVd) for the treatment of adults with multiple myeloma who have received at least one prior therapy. With this approval for the extension of Nexpovio's indication in the European Union (EU), the conditional marketing authorization is now converted to a full approval. The marketing authorization, which marks the second indication for Nexpovio, is valid in all 27 member states of the EU as well as Iceland, Liechtenstein, Norway, and Northern Ireland. Stemline Therapeutics B.V. will be responsible for all commercialization activities in Europe.
|
|
|
|
|
|
|
This Week: IMF Virtual Regional Community Workshop—Pacific Southwest
The IMF Regional Community Workshop (RCW) – Pacific Southwest will be held this Saturday, July 23 at 10 a.m. PT/11 a.m. MDT/12 p.m. CT/ 1 p.m. ET. Guest speakers include Caitlin Costello, MD (University of California San Diego—San Diego, CA); Amrita Krishnan, MD (City of Hope Comprehensive Cancer Center—Duarte, CA); and IMF Nurse Leadership Board Member Donna Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System—New York, NY). IMF Senior Director of Regional Community Workshops Kelly Cox will kick off the workshop, which includes an introduction to myeloma, upfront treatments at diagnosis, maintenance therapy, relapse information, and an update on clinical trials. NLB Member Donna Catamero will talk about managing side effects and symptoms of myeloma and its treatments. After each presentation with the experts, attendees will have ample time to ask questions.
|
|
|
|
|
|
|
New Drugs, Regimens, and Strategies for Multiple Myeloma: Case Studies for Nurses
Presented by Medscape Oncology, this video is designed for healthcare practitioners to earn continuing education (CE) credits. IMF Nurse Leadership Board nurses Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN (Taussig Cancer Institute—Cleveland, Ohio), Donna D. Catamero, ANP-BC, OCN, CCRC (The Mount Sinai Health System—New York, NY), and Kim Noonan, DNP, RN, ANP-BC, AOCN® (Dana-Farber Cancer Institute—Boston, MA) discuss new drugs, regimens, and strategies for multiple myeloma. To earn CE credits, register at Medscape.org and log in.
|
|
|
|
|
|
|
Explore the IMF’s Mind, Body, and Wellness Website
For myeloma patients and caregivers, health and wellness should always be top priority. The Mind, Body, and Wellness section of the IMF website provides wellness education, movement, exercise, and mindfulness practices tailored to meet the needs of patients and caregivers. Self-advocate for your physical, emotional, and spiritual well-being by beginning your mind and body journey with us.
|
|
|
|
|
|
|
Laughs 4 Life Returns to Hattiesburg on July 29
Laughs 4 Life returns to Hattiesburg, MS on Friday, July 29 with Leanne Morgan and special guests, James Austin Johnson and Keith Alberstadt. Proceeds of the comedy show will benefit the IMF and other organizations. For over 4 years, Laughs 4 Life has been funding the IMF’s Brian D. Novis Research Grants. For more information on sponsorships, tickets, auction, and the program, visit www.laughs4life.com. You may also donate online through the IMF website if you are unable to attend the event.
|
|
|
|
|
|
|
#ASKDRDURIE | Dr. Durie's Weekly Web Video Series
What were the results of the DETERMINATION Trial presented at ASCO and EHA?
|
|
|
|
|
|
Instagram @IMFmyeloma